Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral microbial cells and volatile sulfur compound (VSC)-producing systems represent a complex biological target primarily responsible for oral malodor, or halitosis. This system consists of a diverse community of anaerobic Gram-negative bacteria, such as Porphyromonas gingivalis, Prevotella intermedia, and Fusobacterium nucleatum, which reside in dental plaque and on the tongue dorsum (Source: PubMed, PMID: 24564061). These microbes utilize proteolytic enzymes to degrade sulfur-containing amino acids like cysteine and methionine into VSCs, including hydrogen sulfide and methyl mercaptan (Source: NIH, StatPearls). Therapeutic interventions target this system through broad-spectrum antimicrobials that reduce bacterial load or through chemical agents like zinc salts that inhibit the enzymatic pathways and neutralize the volatile products (Source: Journal of Clinical Periodontology). Managing this system is crucial not only for social hygiene but also because VSCs are toxic to oral tissues and can exacerbate periodontal disease by increasing mucosal permeability and inducing inflammation.
The primary mechanism involves the reduction of the microbial load through broad-spectrum antiseptics like chlorhexidine and cetylpyridinium chloride, which disrupt bacterial cell membranes (Source: PubMed, PMID: 12787205). Additionally, metal ions such as zinc (Zn2+) act by inhibiting the thiol-containing enzymes required for VSC production and by directly binding to gaseous VSCs to form non-volatile metal sulfides (Source: NIH, PMC3633300). Oxidizing agents like chlorine dioxide and hydrogen peroxide chemically oxidize VSCs into odorless sulfates.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral microbiome and volatile sulfur compound-producing systems (VSC-producing systems).